Berlin, Germany

Matthias Busemann

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 7.7

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: The Innovative Contributions of Matthias Busemann

Introduction

Matthias Busemann is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various medical conditions. With a total of four patents to his name, Busemann's work has the potential to impact the treatment of several serious health issues.

Latest Patents

Busemann's latest patents include innovative compounds such as 2,3-benzodiazepines. These compounds are described as BET protein-inhibitory, specifically targeting BRD4. The general formula (I) outlines the specific components of these compounds, which are designed for the prophylactic and therapeutic use in treating hyperproliferative disorders, including tumor disorders. Additionally, the patents discuss the use of BET protein inhibitors for various conditions, such as benign hyperplasias, atherosclerotic disorders, sepsis, autoimmune disorders, and neurodegenerative disorders. Another significant patent involves Estra-1,3,5(10),16-tetraene-3-carboxamides, which serve as inhibitors of 17.beta.-hydroxysteroid dehydrogenase (AKR1C3). This invention focuses on the treatment and prevention of diseases, particularly bleeding disorders and endometriosis.

Career Highlights

Throughout his career, Matthias Busemann has worked with prominent companies, including Bayer Pharma Aktiengesellschaft. His experience in the pharmaceutical industry has allowed him to develop and refine his innovative ideas into practical applications. Busemann's work is characterized by a commitment to advancing medical science and improving patient outcomes.

Collaborations

Busemann has collaborated with notable colleagues, including Ulrich Bothe and Oliver Martin Fischer. These partnerships have likely contributed to the success of his inventions and the development of his patents.

Conclusion

Matthias Busemann's contributions to the field of pharmaceuticals through his innovative patents demonstrate his dedication to addressing critical health challenges. His work continues to pave the way for advancements in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…